10/5/2026
Psyence BioMed to manufacture ibogaine in Texas with Benuvia
Psyence BioMed partners with Benuvia for U.S. ibogaine production, aiming to advance clinical research.
Topic archive
john thorne
4 stories
9/28/2026
Psyence Biomedical secures $1.3M ibogaine licensing deal
Texas subsidiary gains exclusive U.S. rights to PsyLabs' ibogaine
9/23/2026
Psyence BioMed announces ibogaine investment and trial plans
Psyence BioMed to invest $5M in PsyLabs, plans Texas ibogaine trial.
9/14/2026
Psyence BioMed forms Texas entity for U.S. ibogaine research
Texas Ibogaine Research Corporation to spearhead U.S. ibogaine development efforts.